Danielle Grindley

Central Monitoring Lead @Astellas Pharma

Nottingham, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2024 — Present

Central Monitoring Lead @Astellas Pharma

View department →

EDUCATION

2014 — 2016

The University of Sheffield

Postgraduate Diploma in Public Health

2011 — 2014

Northumbria University

BSc (hons) Biomedical Science

ABOUT DANIELLE GRINDLEY

Please note content and comments expressed on this page are my own and not representative of Astellas * I’m an experienced Risk-Based Quality Management (RBQM) professional in the pharmaceutical industry, specializing in driving RBQM adoption, central risk surveillance, and quality risk governance for global clinical trials. I have a proven track record of partnering with cross-functional teams to identify and mitigate critical-to-quality risks, implement IQRMPs, define QTLs/KRIs, and conduct ongoing risk surveillance. My experience spans working closely with study teams, data analytics experts, and system configuration teams to ensure robust, inspection-ready quality oversight. • 4+ years of hands-on RBQM implementation and leadership • Expertise in GCP compliance (ICH E6/E8, 21 CFR Part 11) • Strong record supporting audits & inspections, driving CAPA implementation • Collaborative leader who coaches teams to embed RBQM into study culture • Passionate about transforming trial quality through better data, analytics & proactive governance

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Danielle Grindley — Central Monitoring Lead at Astellas Pharma in Nottingham, GB | Unifers